4//SEC Filing
DEXCOM INC 4
Accession 0001093557-17-000076
$DXCMCIK 0001093557operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:59 PM ET
Size
20.0 KB
Accession
0001093557-17-000076
Insider Transaction Report
Form 4
DEXCOM INCDXCM
VALDES JORGE A
SVP of Operations
Transactions
- Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−6,694$519,124→ 28,806 total(indirect: By Trust) - Other
Common Stock
2017-03-10$78.24/sh−7,500$586,800→ 53,000 total - Other
Common Stock
2017-03-10$78.24/sh−11,834$925,892→ 60,500 total - Other
Common Stock
2017-03-10$78.24/sh+12,667$991,066→ 35,500 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−3,964$307,411→ 24,842 total(indirect: By Trust) - Other
Common Stock
2017-03-10$78.24/sh−12,667$991,066→ 40,333 total - Disposition to Issuer
Common Stock
2017-03-10$77.55/sh−6,254$485,001→ 34,079 total - Other
Common Stock
2017-03-10$78.24/sh+11,834$925,892→ 15,333 total(indirect: By Trust) - Other
Common Stock
2017-03-10$78.24/sh+7,500$586,800→ 22,833 total(indirect: By Trust) - Sale
Common Stock
2017-03-13$77.74/sh−14,400$1,119,514→ 10,442 total(indirect: By Trust)
Footnotes (7)
- [F1]Shares were transferred from direct ownership to ownership under the Valdes-Lopez-Calleja Family Trust upon vesting of previously awarded restricted stock units.
- [F2]Included in this number are 40,333 unvested restricted stock units, 25,333 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 15,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018.
- [F3]These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- [F4]Shares are held by the Jorge Alberto Valdes and Suzanne Lopez-Calleja, cotrustees of the Valdes-Lopez-Calleja Family Trust, dated May 18, 2011.
- [F5]Shares are held by the Valdes-Lopez-Calleja Family Trust U/A/D 05/18/2011, with respect to which the reporting person is a trustee.
- [F6]On November 4, 2016 Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F7]This transaction was executed in multiple trades at prices ranging from $77.41 to $78.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001093557
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 7:59 PM ET
- Size
- 20.0 KB